https://medicine.ouhsc.edu/directory Parent Page: Directory id: 22535 Active Page: Detailsid:23325

Directory

Categories

Bradley C Gehrs, MD
Pathology

Bradley C. Gehrs, MD

Assistant Professor
Clinical Pathology
Hematopathology

The University of Oklahoma Health Sciences Center
Children's Hospital
1200 N. Everett Dr 
ET-B406
Oklahoma City, OK 73104

405-271-7515

bradley-gehrs@ouhsc.edu

Academic Section(s):

Pathology

Education:

  • BS - Chemistry, Biology and Mathematics, Valparaiso University, Valparaiso, IN (1989)
  • MD - University of North Carolina School of Medicine, Chapel Hill, NC (1995-1997)

Residency:

  • Anatomic and Clinical Pathology  - University of Alabama School of Medicine (1997-2002)

Fellowship:

  • Transfusion Medicine Fellowship - University of Alabama School of Medicine (2000-2001)
  • Postdoctoral Research Fellowship - University of Alabama School of Medicine (2002-2006)
  • Hematopathology Fellowship - Wayne State University/Detroit Medical Center (2007-2008)

Select Publications:

  1. Gehrs BC, Riddle MM, Williams WC, Smialowicz RJ. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. II. Effects on the pup and the adult. Toxicology. 1997 Oct 19;122(3):229-40.

  2. Gehrs BC, Smialowicz RJ. Persistent suppression of the delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.Toxicology. 1999 May 3;134(1):79-88.

  3. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002 Apr;69(4):258-71.

  4. Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD. Ex vivo expanded human Vγ9Vδ2+ γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J Urol. 2005 May;173(5):1552-6.

  5. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS: Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res. 2006 Jul;4(7):437-47.

  6. Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS. Differential effects of Ca2+ on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol. 2007 Mar 15;559(1):21-31.

  7. Beavers C, Harrison M, Gehrs B, Blick KE, Lethargy and seizures in a 52-year-old male, Lab Med, July 2009; 40(7);405-407.

  8. Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, Anver MR, Shoemaker RH, Milillo G. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther July 2009;8(7):1867-1877.

  9. Al-Kali A, Cherry M, Kimmel K, Holter J, Kern W, Gehrs B, Ozer H, Selby G. A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)? [Letter to the Editor] Cancer Genet Cytogenet Dec 2010;203(2):348-51.

  10. Fung KM, Chakrabarty JH, Kern WF, Magharyous H, Gehrs BC, Li S. Case Report: Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient. Int J Clin Exp Pathol 2012;5(5):448-454. (Online only journal)